618
Participants
Start Date
August 31, 2006
Primary Completion Date
May 5, 2008
Study Completion Date
May 5, 2008
inhaled human insulin
Treat-to-target dose titration scheme, inhalation.
insulin detemir
Injection s.c., 50% of daily dose.
insulin aspart
Treat-to-target dose titration scheme, injection s.c.
insulin aspart
Treat-to-target dose titration scheme, injection s.c. After 2 years.
Novo Nordisk Investigational Site, Taipei
Novo Nordisk Investigational Site, Taipei
Novo Nordisk Investigational Site, Taichung
Novo Nordisk Investigational Site, Hvidovre
Novo Nordisk Investigational Site, Elche
Novo Nordisk Investigational Site, Hillerød
Novo Nordisk Investigational Site, Århus C
Novo Nordisk Investigational Site, Cáceres
Novo Nordisk Investigational Site, Narbonne
Novo Nordisk Investigational Site, La Rochelle
Novo Nordisk Investigational Site, Granada
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Hamburg
Novo Nordisk Investigational Site, Hamburg
Novo Nordisk Investigational Site, Neumünster
Novo Nordisk Investigational Site, Lugo
Novo Nordisk Investigational Site, Mostoles - Madrid -
Novo Nordisk Investigational Site, Brest
Novo Nordisk Investigational Site, Toulouse
Novo Nordisk Investigational Site, Warburg
Novo Nordisk Investigational Site, Verona
Novo Nordisk Investigational Site, Bad Lauterberg im Harz
Novo Nordisk Investigational Site, Grenoble
Novo Nordisk Investigational Site, Bad Harzburg
Novo Nordisk Investigational Site, Seville
Novo Nordisk Investigational Site, Xátiva
Novo Nordisk Investigational Site, Valladolid
Novo Nordisk Investigational Site, Bad Kreuznach
Novo Nordisk Investigational Site, Pisa
Novo Nordisk Investigational Site, Neuwied
Novo Nordisk Investigational Site, Nevers
Novo Nordisk Investigational Site, Holon
Novo Nordisk Investigational Site, Pescara
Novo Nordisk Investigational Site, Friedrichsthal
Novo Nordisk Investigational Site, Völklingen
Novo Nordisk Investigational Site, Saint Ingbert
Novo Nordisk Investigational Site, Strasbourg
Novo Nordisk Investigational Site, Speyer
Novo Nordisk Investigational Site, Bari
Novo Nordisk Investigational Site, San Giovanni Rotondo
Novo Nordisk Investigational Site, Herrenberg
Novo Nordisk Investigational Site, Beersheba
Novo Nordisk Investigational Site, Catanzaro
Novo Nordisk Investigational Site, Jerusalem
Novo Nordisk Investigational Site, Nanterre
Novo Nordisk Investigational Site, Catania
Novo Nordisk Investigational Site, Singapore
Novo Nordisk Investigational Site, Singapore
Novo Nordisk Investigational Site, Campinas
Novo Nordisk Investigational Site, Higienópolis
Novo Nordisk Investigational Site, Porto Alegre
Novo Nordisk Investigational Site, São Paulo
Novo Nordisk Investigational Site, Dresden
Novo Nordisk Investigational Site, Dresden
Novo Nordisk Investigational Site, Hohenmölsen
Novo Nordisk Investigational Site, Schkeuditz
Novo Nordisk Investigational Site, Shatin, New Territories
Novo Nordisk Investigational Site, Perugia
Novo Nordisk Investigational Site, Roma
Novo Nordisk Investigational Site, Roma
Novo Nordisk Investigational Site, Almería
Novo Nordisk Investigational Site, Aberdeen
Novo Nordisk Investigational Site, Ayr
Novo Nordisk Investigational Site, Bristol
Novo Nordisk Investigational Site, Cosham
Novo Nordisk Investigational Site, Edgbaston, Birmingham
Novo Nordisk Investigational Site, Edinburgh
Novo Nordisk Investigational Site, Livingstone
Novo Nordisk Investigational Site, Nottingham
Novo Nordisk Investigational Site, Plymouth
Novo Nordisk Investigational Site, Salford
Novo Nordisk Investigational Site, Sheffield
Novo Nordisk Investigational Site, Wirral, Merseyside
Lead Sponsor
Novo Nordisk A/S
INDUSTRY